Coronavirus: Vaccination

Department of Health and Social Care written question – answered on 13th June 2022.

Alert me about debates like this

Photo of Rachael Maskell Rachael Maskell Labour/Co-operative, York Central

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the long-term effectiveness of covid-19 booster vaccines.

Photo of Alexander Stafford Alexander Stafford Conservative, Rother Valley

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the long-term effectiveness of covid-19 booster vaccines.

Photo of Maggie Throup Maggie Throup The Parliamentary Under-Secretary for Health and Social Care

The UK Health Security Agency continues to work with the Medicines and Healthcare products Regulatory Agency, NHS England and other government, devolved administration and academic partners to monitor the COVID-19 vaccination programme. Several studies of vaccine effectiveness have been conducted in the United Kingdom against different COVID-19 variants and continue to be updated.

Post implementation effectiveness studies are required to understand vaccine effectiveness against outcomes such as severe disease and onwards transmission, effectiveness in different subgroups of the population, against different variants and the duration of protection. Vaccine effectiveness is estimated by comparing rates of disease in vaccinated individuals to rates in unvaccinated individuals. Where available, we are focusing on data related to the Omicron variant which is currently dominant in the UK.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.